Shuwei Chen

Papers

Total Citations

H-Index

About

Shuwei Chen is a leading surgical oncologist whose research focuses on the treatment of oropharyngeal squamous cell carcinoma (OPSCC), particularly through the application of transoral robotic surgery (TORS). Dr. Chen’s major contributions center on evaluating the clinical safety and efficacy of TORS for both HPV-positive and HPV-negative OPSCC, providing critical insights into surgical outcomes in Chinese patient populations. Their landmark 2023 study, “Analysis of T1‐T2 stage oropharyngeal squamous cell carcinoma treated with transoral robotic surgery,” has already garnered 12 citations, underscoring its timely impact on the field. By systematically analyzing early-stage disease management, Dr. Chen has helped refine surgical protocols and expand the evidence base for robotic-assisted approaches in head and neck oncology. This work is particularly notable for addressing regional differences in HPV-related cancer epidemiology, offering tailored recommendations that bridge global best practices with local clinical realities. Dr. Chen’s research continues to shape minimally invasive surgical strategies, improving patient recovery and survival outcomes. Their dedication to advancing robotic surgery techniques marks them as a key contributor to modern oncologic care.